Skip to main content

Day: November 16, 2023

Breakthrough Ventures Acquires Penguin Wellness in All-Cash Deal

NEW YORK, Nov. 16, 2023 (GLOBE NEWSWIRE) — FE International, Inc., the global market leader in mid-market technology mergers and acquisitions (M&A), is pleased to announce the acquisition of Penguin Wellness, an ultra-luxury supplement brand, by Breakthrough Ventures, a health and wellness holding company. Purchased by Verma Brands in 2021, Penguin’s flagship product includes its robust CBD product line, as well as its protein powder, pre-workout, and collagen SKUs. With a focus on high-end products, the company has established itself as one of the most recognized names within the CBD space. For the owner of Verma Brands, AJ Agrawal, this marks the second acquisition in the past four years. Agrawal sold Verma Farms for eight figures in 2021. The owner of Penguin Wellness, AJ Agrawal, will sell his entire interest in the business...

Continue reading

Qifu Technology Announces Third Quarter 2023 Unaudited Financial Results

SHANGHAI, China, Nov. 16, 2023 (GLOBE NEWSWIRE) — Qifu Technology, Inc. (NASDAQ: QFIN; HKEx: 3660) (“Qifu Technology” or the “Company”), a leading Credit-Tech platform in China, today announced its unaudited financial results for the third quarter ended September 30, 2023. Third Quarter 2023 Business HighlightsAs of September 30, 2023, our platform has connected 155 financial institutional partners and 227.9 million consumers*1 with potential credit needs, cumulatively, an increase of 12.0% from 203.5 million a year ago. Cumulative users with approved credit lines*2 were 49.2 million as of September 30, 2023, an increase of 14.4% from 43.0 million as of September 30, 2022. Cumulative borrowers with successful drawdown, including repeat borrowers was 29.4 million as of September 30, 2023, an increase of 11.9% from 26.3 million...

Continue reading

Post Holdings Reports Results for the Fourth Quarter and Fiscal Year 2023

ST. LOUIS, Nov. 16, 2023 (GLOBE NEWSWIRE) — Post Holdings, Inc. (NYSE:POST), a consumer packaged goods holding company, today reported results for the fourth fiscal quarter and fiscal year ended September 30, 2023. Highlights:Fourth quarter net sales of $1.9 billion; operating profit of $153.0 million; net earnings from continuing operations of $65.7 million and Adjusted EBITDA (non-GAAP)* of $349.0 million Fiscal year net sales of $7.0 billion; operating profit of $598.9 million; net earnings from continuing operations of $301.3 million and Adjusted EBITDA of $1,233.4 million Fiscal year 2024 Adjusted EBITDA (non-GAAP)* expected to range between $1,200-$1,260 million*For additional information regarding non-GAAP measures, such as Adjusted EBITDA, Adjusted net earnings from continuing operations, Adjusted diluted earnings from...

Continue reading

U.S. Global Investors Announces Solid Financial Results for Fiscal Year 2023, with Net Income Per Share of $0.22, 23% Operating Margin and Increased Working Capital

JETS Outperformed the Market and Airline StocksBloomberg, U.S. Global InvestorsSAN ANTONIO, Nov. 16, 2023 (GLOBE NEWSWIRE) — U.S. Global Investors, Inc. (NASDAQ: GROW) (the “Company”), a registered investment advisory firm with longstanding experience in global markets and specialized sectors from gold to airlines, is pleased to report financial results for the fiscal year ended June 30, 2023. For the 12-month period, net income was $3.1 million, or $0.22 per share, and operating income was $3.5 million. Operating margin was a healthy 23% on operating revenues of $15.1 million, despite average assets under management (AAUM) declining 35.6%, from $3.9 million during fiscal 2022 to $2.5 million during the fiscal year ended June 30, 2023. As of June 30, 2023, the Company had net working capital of approximately $37.4 million,...

Continue reading

Amalgamated Financial Corp. Appoints Julieta Ross and Scott Stoll to its Board of Directors

NEW YORK, Nov. 16, 2023 (GLOBE NEWSWIRE) — Amalgamated Financial Corp. (“Amalgamated” or the “Company”) (Nasdaq: AMAL) today announced it has appointed Julieta Ross and Scott Stoll as its newest members to the Company’s Board of Directors, effective immediately. Dr. Ross has an extensive background in the broader financial services risk management landscape, with over 20 years of global banking technology leadership and experience. With a proven track record of building and scaling businesses while leveraging digital technologies, she offers a vast understanding on the integration of new technology perspectives in the process of building market-leading banking platforms and avant-garde digital capabilities. Mr. Stoll is a recognized leader with over 40 years of experience in the banking, insurance, and asset management industries,...

Continue reading

Gerald Haddock to Retire from Meritage Homes Board of Directors

Deborah Ann Henretta Appointed Nominating/Governance Committee Chair SCOTTSDALE, Ariz., Nov. 16, 2023 (GLOBE NEWSWIRE) — Meritage Homes Corporation (NYSE:MTH) (the “Company”), the fifth largest homebuilder in the U.S., today announced that one of the Company’s long-standing directors, Mr. Gerald Haddock, is retiring from his position effective January 2, 2024. Mr. Haddock joined Meritage’s Board in 2005 and has served as Chair of the Nominating/Governance Committee since 2006. “On behalf of the Board, I’d like to thank Gerald for his 18 years of service and contributions to Meritage,” said Steven J. Hilton, executive chairman of Meritage Homes. “In his tenure, Gerald has overseen several important initiatives, including the successful succession planning and transition of the Company’s executive leadership team today and the promotion...

Continue reading

Alpha Tau Medical Announces Third Quarter 2023 Financial Results and Provides Corporate Update

– Treated the first patient with advanced inoperable pancreatic cancer at Hadassah Medical Center in Israel in September, alongside safety and feasibility trial in similar indication currently underway in Montreal, Canada – – 89% CR, two-year local recurrence-free survival of 77%, and no treatment-related grade 2 or higher late-onset toxicity reported from an analysis of four feasibility trials in 71 patients with unresectable skin and head and neck cancers – – Former U.S. FDA Commissioner, Stephen M. Hahn, M.D. appointed to Alpha Tau Scientific Advisory Board – – Cash, deposits & restricted deposits balance of $90.1 million with runway for at least two years – JERUSALEM, Nov. 16, 2023 (GLOBE NEWSWIRE) — Alpha Tau Medical Ltd. (“Alpha Tau”, or the “Company”) (NASDAQ:...

Continue reading

ESCO Announces Record Fourth Quarter And Fiscal 2023 Results

– FY 2023 Sales increase 11% to $956 Million – FY 2023 Entered Orders surpass $1 Billion – Q4 GAAP EPS $1.24 / Adjusted EPS $1.25 – St. Louis, Nov. 16, 2023 (GLOBE NEWSWIRE) — ESCO Technologies Inc. (NYSE: ESE) (ESCO, or the Company) today reported its operating results for the fourth quarter (Q4 2023) and fiscal year (FY 2023) ended September 30, 2023. Operating HighlightsQ4 2023 sales increased $16 million (6 percent) to $273 million compared to $257 million in Q4 2022. Organic sales increased $13 million (5 percent) and the CMT acquisition added $3 million (1 percent) of revenue growth in the quarter. FY 2023 sales increased $99 million (11 percent) to $956 million. Organic sales increased $89 million (10 percent) and the CMT acquisition added $10 million (1 percent) of revenue growth for the full year....

Continue reading

Matthews International Reports Results for Fourth Quarter and Fiscal Year Ended September 30, 2023

Financial Highlights:Consolidated sales in fourth quarter increased $23.1 million, or 5.0% Industrial Technologies sales 34% higher for the quarter; FY2023 sales exceed $500 million, compared to $335.5 million for FY2022 All three business segments reported higher adjusted EBITDA for the quarter Company expects continued earnings growth and strong cash flow in fiscal 2024 Webcast: Friday, November 17, 2023, 9:00 a.m., (201) 689-8471PITTSBURGH, Nov. 16, 2023 (GLOBE NEWSWIRE) — Matthews International Corporation (NASDAQ GSM: MATW) today announced financial results for the quarter and fiscal year ended September 30, 2023. In discussing the Company’s operating results, Joseph C. Bartolacci, President and Chief Executive Officer, stated: “We had a strong finish to fiscal 2023 as demonstrated by our fourth quarter results. I am pleased...

Continue reading

Embassy Bancorp, Inc. Announces Results of Operations as of and for the Three and Nine Months ended September 30, 2023

BETHLEHEM, Pa., Nov. 16, 2023 (GLOBE NEWSWIRE) — Embassy Bancorp, Inc. (OTCQX: EMYB) (the “Company”) has filed its Form 10-Q on November 13, 2023 and can be found at https://investors.embassybank.com/sec-filings/documents/default.aspx. Highlights of the filing, which includes consolidated financial information of the Company and Embassy Bank For the Lehigh Valley (the “Bank”), the Company’s wholly-owned subsidiary, include:Loans receivable increased to $1.249 billion at September 30, 2023, an increase of $41.0 million, or 4.5% on an annualized basis, from $1.208 billion at December 31, 2022. Cash and cash equivalents on hand of $77.7 million at September 30, 2023, or 4.6% of total assets. Deposits of $1.472 billion at September 30, 2023, with non-interest bearing deposits of $320.7 million. The Company does not have any brokered...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.